ClinicalTrials.gg
CompletedNCT05412368EnCAMHSUpdated Feb 28, 2024

Enhancing Referrals to Child and Adolescent Mental Health Services: EnCAMHS

An observational study in Mental Health Issue, sponsored by Greater Manchester Mental Health NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-28.

Sponsored by Greater Manchester Mental Health NHS Foundation Trust · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
110
Ages
16 Years and older
Sex
All
01

Study summary

Our aim is to find low-cost and widely reusable mechanisms to reduce inappropriate referrals. Our key objectives are:

Engage with key stakeholders to identify problems with making appropriate referrals Analyse CAMHS referral data to understand and identify problems (quantitatively) Identify requirements for sustainable solutions Explore with key stakeholders how we can improve the referral process Identify how the best proposed solutions could be embedded within routine CAMHS referral pathways

Read the detailed description

The Investigators shall conduct a series of focus groups with key stakeholders involved in the referral to CAMHS process; children and young people (CYP), parents/carers, key referrers, CAMHS professionals in order to better understand the challenges that exist with the current referral process. Following this, the Investigators will conduct further focus groups with the key stakeholders above, in which they will suggest sustainable solutions to the problems that have been identified.

The Investigators shall then identify how the propose solutions can be embedded into routine CAMHS referral pathways.

02

Conditions studied

  • Mental Health Issue
03

In context

Lead sponsor

Greater Manchester Mental Health NHS Foundation Trust is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Anyone aged 16 and above who has been involved in the CAMHS referral pathway

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 16 years and above
  • have experience of CAMHS referral pathway

Exclusion criteria

Exclusion Criteria:

  • younger than 16 years
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
110 participants (actual)
Patient registry
No

Groups and cohorts

  • Children and young people (CYP)

    Children and young people who have been referred to CAMHS

    Other: Focus Groups

  • Parents/carers

    Parents/carers of CYP who have been referred to CAMHS

    Other: Focus Groups

  • Key referrers

    Key referrers (e.g. Teachers, GPs, SENCOs, Social Workers) who have referred CYP to CAMHS

    Other: Focus Groups

  • CAMHS Professionals

    CAMHS Professionals who have received referrals to CAMHS

    Other: Focus Groups

Interventions

  • OtherFocus Groups

    Focus Groups

06

What researchers measure

Primary outcomes

  1. Solutions to enhance the referral process for CAMHS

    Solutions to help improve the referrals into CAMHS, using data collected during focus groups

    Time frame: By end of study - within 1 year

07

Study locations

1 site
  • University of Manchester
    Manchester, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — We will not be sharing IPD

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2021 to primary completion in May 2022, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2022
First posted
Jun 9, 2022
StartActual
Nov 1, 2021
Primary completionActual
May 1, 2022
CompletionActual
Jun 30, 2023
Last update
Feb 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05412368
Lead sponsor
Greater Manchester Mental Health NHS Foundation Trust
Collaborators
University of Manchester, Manchester University NHS Foundation Trust, Pennine Care NHS Foundation Trust, Northumberland, Tyne and Wear NHS Foundation Trust, MQ Mental Health, Anna Freud National Centre for Children and Families, McPin Foundation, 42nd Street
Responsible party
Kathryn Abel (Professor Kathryn Abel, Greater Manchester Mental Health NHS Foundation Trust) — Principal investigator
First posted
Jun 9, 2022
Start date
Nov 1, 2021
Primary completion
May 1, 2022
Completion
Jun 30, 2023
Last update
Feb 28, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion